SCHEMBL7329283

SCHEMBL7329283

N#Cc1ccccc1C[C@@H]1CO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
CYP19A1 P11511 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
P2RX7 Q99572 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
HSD11B1 P28845 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GLA P06280 1/20 0.36
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6508006 1.00 TSHR (0.41) TSHRCYP19A1TDP1ALDH1A1SMN1; SMN2
SCHEMBL7331133 1.00 TSHR (0.41) TSHRCYP19A1TDP1ALDH1A1SMN1; SMN2
SCHEMBL9182510 0.81 TDP1 (0.35) TSHRTDP1ALDH1A1SMN1; SMN2GLA
SCHEMBL29826970 0.80 TDP1 (0.45) TSHRTDP1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL6480647 0.80 TDP1 (0.45) TSHRTDP1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL27895212 0.78 SLC6A2 (0.46) SLC6A2SLC6A4
Ammonia Solution, Strong SCHEMBL27798784 0.78 TDP1 (0.43) TSHRTDP1ALDH1A1SMN1; SMN2KMT2A
Methane SCHEMBL27917831 0.78 TDP1 (0.43) TSHRTDP1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL28454337 0.74 TDP1 (0.41) TSHRTDP1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL30607492 0.74 TDP1 (0.41) TSHRTDP1ALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5204463-A Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities GLAXO INC. (US) 1993-04-20 US disclosed
US-5096904-A Congestive heart failure GLAXO INC. (US) 1992-03-17 US disclosed
US-5053338-A Hydrolysis of ester to obtain an optically enriched mixture of a phenol enantiomer GLAXO INC. (US) 1991-10-01 US disclosed
EP-0412814-A2 Pyridazinones having cardiotonic and beta blocking activity GLAXO WELLCOME INC. (US) 1991-02-13 EP disclosed